+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples, Oral Fluid Samples), By Drug (Alcohol, Cannabis/Marijuana, Cocaine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5415568
Description Jump to:
The global drug testing market size is expected to reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 to 2030, according to a new report.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA's 510(k) clearance to market its fluorescence immunoassay - Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Drug Testing Market Report Highlights

  • By product type, the consumables segment dominated the market in 2023, owing to its repetitive use to conduct substance abuse screening
  • Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection
  • Increased unemployment and economic crisis due to the COVID-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market
  • The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions
  • Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth
  • In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Sample
1.2.3. Drug
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Sample outlook
2.2.3. Drug outlook
2.2.4. End Use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Drug Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of substance abuse
3.2.1.2. Stringent laws mandating alcohol and drug testing
3.2.1.3. Increasing government initiatives to monitor substance abuse
3.2.2. Market restraint analysis
3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
3.3. Drug Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Drug Testing Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Drug Testing Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Consumables
4.4.1.1. Consumables Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Instruments Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Testing Devices
4.4.3.1. Rapid Testing Devices Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Services
4.4.4.1. Services Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Drug Testing Market: Sample Estimates & Trend Analysis
5.1. Sample Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Drug Testing Market by Sample Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Urine Samples
5.4.1.1. Urine Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Oral Fluid Samples
5.4.2.1. Oral Fluid Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hair Samples
5.4.3.1. Hair Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Other Samples
5.4.4.1. Other Samples Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Drug Testing Market: Drug Type Estimates & Trend Analysis
6.1. Drug Type Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Drug Testing Market by Drug type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Alcohol
6.4.1.1. Alcohol Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Cannabis/Marijuana
6.4.2.1. Cannabis/Marijuana Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Cocaine
6.4.3.1. Cocaine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Opioids
6.4.4.1. Opioids market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Amphetamine & Methamphetamine
6.4.5.1. Amphetamine & Methamphetamine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. LSD
6.4.6.1. LSD Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Drug Testing Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Drug Testing Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Drug Testing Laboratories
7.4.1.1. Drug Testing Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Workplaces
7.4.2.1. Workplaces Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Hospitals
7.4.3.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Drug Testing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Mexico
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Argentina
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Quest Diagnostics Incorporated
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Services benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Abbott
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Services benchmarking
9.3.5.4. Strategic initiatives
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Services benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Quidel Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Services benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Thermo Fisher Scientific, Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Services benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Siemens Healthcare GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Services benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Bio-Rad Laboratories, Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Services benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Agilent Technologies, Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Services benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Laboratory Corporation of America Holdings
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Services benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Clinical Reference Laboratory, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Services benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Cordant Health Solutions
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Services benchmarking
9.3.14.4. Strategic initiatives
Chapter 10. Conclusion
List of Tables
Table 1 List of abbreviation
Table 2 North America drug testing market, by region, 2018 - 2030 (USD Million)
Table 3 North America drug testing market, by products, 2018 - 2030 (USD Million)
Table 4 North America drug testing market, by sample, 2018 - 2030 (USD Million)
Table 5 North America drug testing market, by drug, 2018 - 2030 (USD Million)
Table 6 North America drug testing market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. drug testing market, by products, 2018 - 2030 (USD Million)
Table 8 U.S. drug testing market, by sample, 2018 - 2030 (USD Million)
Table 9 U.S. drug testing market, by drug, 2018 - 2030 (USD Million)
Table 10 U.S. drug testing market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada drug testing market, by products, 2018 - 2030 (USD Million)
Table 12 Canada drug testing market, by sample, 2018 - 2030 (USD Million)
Table 13 Canada drug testing market, by drug, 2018 - 2030 (USD Million)
Table 14 Canada drug testing market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe drug testing market, by region, 2018 - 2030 (USD Million)
Table 16 Europe drug testing market, by products, 2018 - 2030 (USD Million)
Table 17 Europe drug testing market, by sample, 2018 - 2030 (USD Million)
Table 18 Europe drug testing market, by drug, 2018 - 2030 (USD Million)
Table 19 Europe drug testing market, by end use, 2018 - 2030 (USD Million)
Table 20 Germany drug testing market, by products, 2018 - 2030 (USD Million)
Table 21 Germany drug testing market, by sample, 2018 - 2030 (USD Million)
Table 22 Germany drug testing market, by drug, 2018 - 2030 (USD Million)
Table 23 Germany drug testing market, by end use, 2018 - 2030 (USD Million)
Table 24 UK drug testing market, by products, 2018 - 2030 (USD Million)
Table 25 UK drug testing market, by sample, 2018 - 2030 (USD Million)
Table 26 UK drug testing market, by drug, 2018 - 2030 (USD Million)
Table 27 UK drug testing market, by end use, 2018 - 2030 (USD Million)
Table 28 France drug testing market, by products, 2018 - 2030 (USD Million)
Table 29 France drug testing market, by sample, 2018 - 2030 (USD Million)
Table 30 France drug testing market, by drug, 2018 - 2030 (USD Million)
Table 31 France drug testing market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy drug testing market, by products, 2018 - 2030 (USD Million)
Table 33 Italy drug testing market, by sample, 2018 - 2030 (USD Million)
Table 34 Italy drug testing market, by drug, 2018 - 2030 (USD Million)
Table 35 Italy drug testing market, by end use, 2018 - 2030 (USD Million)
Table 36 Spain drug testing market, by products, 2018 - 2030 (USD Million)
Table 37 Spain drug testing market, by sample, 2018 - 2030 (USD Million)
Table 38 Spain drug testing market, by drug, 2018 - 2030 (USD Million)
Table 39 Spain drug testing market, by end use, 2018 - 2030 (USD Million)
Table 40 Denmark drug testing market, by products, 2018 - 2030 (USD Million)
Table 41 Denmark drug testing market, by sample, 2018 - 2030 (USD Million)
Table 42 Denmark drug testing market, by drug, 2018 - 2030 (USD Million)
Table 43 Denmark drug testing market, by end use, 2018 - 2030 (USD Million)
Table 44 Sweden drug testing market, by products, 2018 - 2030 (USD Million)
Table 45 Sweden drug testing market, by sample, 2018 - 2030 (USD Million)
Table 46 Sweden drug testing market, by drug, 2018 - 2030 (USD Million)
Table 47 Sweden drug testing market, by end use, 2018 - 2030 (USD Million)
Table 48 Norway drug testing market, by products, 2018 - 2030 (USD Million)
Table 49 Norway drug testing market, by sample, 2018 - 2030 (USD Million)
Table 50 Norway drug testing market, by drug, 2018 - 2030 (USD Million)
Table 51 Norway drug testing market, by end use, 2018 - 2030 (USD Million)
Table 52 Asia Pacific drug testing market, by region, 2018 - 2030 (USD Million)
Table 53 Asia Pacific drug testing market, by products, 2018 - 2030 (USD Million)
Table 54 Asia Pacific drug testing market, by sample, 2018 - 2030 (USD Million)
Table 55 Asia Pacific drug testing market, by drug, 2018 - 2030 (USD Million)
Table 56 Asia Pacific drug testing market, by end use, 2018 - 2030 (USD Million)
Table 57 China drug testing market, by products, 2018 - 2030 (USD Million)
Table 58 China drug testing market, by sample, 2018 - 2030 (USD Million)
Table 59 China drug testing market, by drug, 2018 - 2030 (USD Million)
Table 60 China drug testing market, by end use, 2018 - 2030 (USD Million)
Table 61 Japan drug testing market, by products, 2018 - 2030 (USD Million)
Table 62 Japan drug testing market, by sample, 2018 - 2030 (USD Million)
Table 63 Japan drug testing market, by drug, 2018 - 2030 (USD Million)
Table 64 Japan drug testing market, by end use, 2018 - 2030 (USD Million)
Table 65 India drug testing market, by products, 2018 - 2030 (USD Million)
Table 66 India drug testing market, by sample, 2018 - 2030 (USD Million)
Table 67 India drug testing market, by drug, 2018 - 2030 (USD Million)
Table 68 India drug testing market, by end use, 2018 - 2030 (USD Million)
Table 69 South Korea drug testing market, by products, 2018 - 2030 (USD Million)
Table 70 South Korea drug testing market, by sample, 2018 - 2030 (USD Million)
Table 71 South Korea drug testing market, by drug, 2018 - 2030 (USD Million)
Table 72 South Korea drug testing market, by end use, 2018 - 2030 (USD Million)
Table 73 Australia drug testing market, by products, 2018 - 2030 (USD Million)
Table 74 Australia drug testing market, by sample, 2018 - 2030 (USD Million)
Table 75 Australia drug testing market, by drug, 2018 - 2030 (USD Million)
Table 76 Australia drug testing market, by end use, 2018 - 2030 (USD Million)
Table 77 Thailand drug testing market, by products, 2018 - 2030 (USD Million)
Table 78 Thailand drug testing market, by sample, 2018 - 2030 (USD Million)
Table 79 Thailand drug testing market, by drug, 2018 - 2030 (USD Million)
Table 80 Thailand drug testing market, by end use, 2018 - 2030 (USD Million)
Table 81 Latin America drug testing market, by products, 2018 - 2030 (USD Million)
Table 82 Latin America drug testing market, by sample, 2018 - 2030 (USD Million)
Table 83 Latin America drug testing market, by drug, 2018 - 2030 (USD Million)
Table 84 Latin America drug testing market, by end use, 2018 - 2030 (USD Million)
Table 85 Brazil drug testing market, by products, 2018 - 2030 (USD Million)
Table 86 Brazil drug testing market, by sample, 2018 - 2030 (USD Million)
Table 87 Brazil drug testing market, by drug, 2018 - 2030 (USD Million)
Table 88 Brazil drug testing market, by end use, 2018 - 2030 (USD Million)
Table 89 Mexico drug testing market, by products, 2018 - 2030 (USD Million)
Table 90 Mexico drug testing market, by sample, 2018 - 2030 (USD Million)
Table 91 Mexico drug testing market, by drug, 2018 - 2030 (USD Million)
Table 92 Mexico drug testing market, by end use, 2018 - 2030 (USD Million)
Table 93 Argentina drug testing market, by products, 2018 - 2030 (USD Million)
Table 94 Argentina drug testing market, by sample, 2018 - 2030 (USD Million)
Table 95 Argentina drug testing market, by drug, 2018 - 2030 (USD Million)
Table 96 Argentina drug testing market, by end use, 2018 - 2030 (USD Million)
Table 97 MEA drug testing market, by region, 2018 - 2030 (USD Million)
Table 98 MEA drug testing market, by products, 2018 - 2030 (USD Million)
Table 99 MEA drug testing market, by sample, 2018 - 2030 (USD Million)
Table 100 MEA drug testing market, by drug, 2018 - 2030 (USD Million)
Table 101 MEA drug testing market, by end use, 2018 - 2030 (USD Million)
Table 102 South Africa drug testing market, by products, 2018 - 2030 (USD Million)
Table 103 South Africa drug testing market, by sample, 2018 - 2030 (USD Million)
Table 104 South Africa drug testing market, by drug, 2018 - 2030 (USD Million)
Table 105 South Africa drug testing market, by end use, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia drug testing market, by products, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia drug testing market, by sample, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia drug testing market, by drug, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia drug testing market, by end use, 2018 - 2030 (USD Million)
Table 110 UAE drug testing market, by products, 2018 - 2030 (USD Million)
Table 111 UAE drug testing market, by sample, 2018 - 2030 (USD Million)
Table 112 UAE drug testing market, by drug, 2018 - 2030 (USD Million)
Table 113 UAE drug testing market, by end use, 2018 - 2030 (USD Million)
Table 114 Kuwait drug testing market, by products, 2018 - 2030 (USD Million)
Table 115 Kuwait drug testing market, by sample, 2018 - 2030 (USD Million)
Table 116 Kuwait drug testing market, by drug, 2018 - 2030 (USD Million)
Table 117 Kuwait drug testing market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Drug testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and sample segment snapshot
Fig. 10 Drug type and end use segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Immunoassay market, 2023 (USD billion)
Fig. 13 Market dynamics
Fig. 14 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 15 Industry analysis - Porter’s
Fig. 16 Drug testing market: Product type outlook and key takeaways
Fig. 17 Drug testing market: Product type movement analysis
Fig. 18 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Rapid testing devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Drug testing market: Sample type outlook and key takeaways
Fig. 23 Drug testing market: Sample type movement analysis
Fig. 24 Urine samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Oral fluid samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Hair samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Other sample market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Drug testing market: Drug type outlook and key takeaways
Fig. 29 Drug testing market: Drug type movement analysis
Fig. 30 Alcohol market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Cannabis/Marijuana market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Cocaine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Number of clients for cocaine in Europe
Fig. 34 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Amphetamine & methamphetamine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 LSD market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 LSD drug use in the past year among people aged 12 or older; by age group, 2021, in U.S.
Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Drug testing market: End use outlook and key takeaways
Fig. 40 Drug testing market: End use movement analysis
Fig. 41 Drug testing laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Workplaces market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Alcohol use disorder diagnose among age groups
Fig. 46 Alcohol addiction and drug abuse suicide, in 2019 - 2020, in India
Fig. 47 Drug Testing Market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
Fig. 48 Regional marketplace: Key takeaways
Fig. 49 Regional marketplace: Key takeaways
Fig. 50 North America Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 U.S. Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Canada Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Europe Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 UK Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Proportion of adults who reported using a drug in the last year by age
Fig. 59 Key country dynamics
Fig. 60 Germany Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 France Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Italy Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Spain Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Denmark Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Sweden Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Norway Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Rest of Europe Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Japan Drug Testing Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 China Drug Testing Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 India Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 South Korea Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Australia Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Thailand Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Rest of APAC Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Brazil Drug Testing Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Mexico Drug Testing Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Argentina Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Rest of LATAM Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 South Africa Drug Testing Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Saudi Arabia Drug Testing Market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 UAE Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Kuwait Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Rest of MEA Drug Testing Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key company categorization
Fig. 107 Drug testing market share analysis, 2023
Fig. 108 Strategy mapping

Companies Mentioned

  • Quest Diagnostics Incorporated
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 6.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.45 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030 - Product Image

Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Drug of Abuse Testing Market by Component, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Drug of Abuse Testing Market by Component, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Drug Testing Market by Drug Testing Product, Sample Type, End-User - Global Forecast 2025-2030 - Product Image

Drug Testing Market by Drug Testing Product, Sample Type, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Drug Abuse Testing Market Report by Product, Sample (Urine, Oral Fluid, Hair, Breath, and Others), End User, and Region 2024-2032 - Product Image

Drug Abuse Testing Market Report by Product, Sample (Urine, Oral Fluid, Hair, Breath, and Others), End User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Drugs of Abuse Testing - Global Strategic Business Report - Product Image

Drugs of Abuse Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.